Loading...
XHKG2633
Market cap254mUSD
Dec 23, Last price  
1.00HKD
1D
-0.99%
1Q
66.67%
Jan 2017
-41.18%
IPO
-40.83%
Name

Jacobson Pharma Corporation Ltd

Chart & Performance

D1W1MN
XHKG:2633 chart
P/E
7.40
P/S
1.35
EPS
0.14
Div Yield, %
4.74%
Shrs. gr., 5y
-0.11%
Rev. gr., 5y
-0.14%
Revenues
1.47b
-17.80%
926,181,000947,591,0001,083,856,0001,255,957,0001,548,684,0001,478,125,0001,571,459,0001,445,915,0001,595,543,0001,785,579,0001,467,798,000
Net income
267m
+6.34%
172,357,000101,904,000145,610,000179,328,000202,270,000250,561,000215,631,000173,713,000177,666,000251,044,000266,968,000
CFO
484m
-25.28%
150,272,000161,754,000221,450,000163,513,000242,994,000395,708,000375,592,000411,346,000409,758,000648,237,000484,363,000
Dividend
Feb 25, 20250.035 HKD/sh

Profile

Jacobson Pharma Corporation Limited, through its subsidiaries, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally. The company offers generic drugs for various therapeutic categories, including the respiratory, cardiovascular, central nervous system, gastrointestinal, genito-urinary, musculoskeletal, endocrine and metabolic, dermatological, anti-allergics, scar treatment, oral anti-diabetics, and anti-infective, as well as arsenic trioxide oral solutions, rosuvastatin tablets, and atorvastatin tablets. It also provides branded medicines; health and wellness products; and proprietary Chinese medicines, such as Po Chai pills, Ho Chai Kung Tji Thung San, Tong Tai Chung Woodlok oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling oil, Contractubex, Doan's Ointment, and Col-gan tablets. In addition, it engages in the trading of medical supplies; procurement of packaging materials; sale of healthcare and herbal products; research and development; and property holding activities. Jacobson Pharma Corporation Limited sells its products to hospitals and clinics, and registered pharmacies, as well as to doctors in private and retail outlets, and trading companies. The company was incorporated in 2016 and is headquartered in Kwun Tong, Hong Kong. Jacobson Pharma Corporation Limited is a subsidiary of Kingshill Development Limited.
URL
http://www.jacobsonpharma.com/
IPO date
Sep 21, 2016
Employees
1,789
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
1,467,798
-17.80%
1,785,579
11.91%
1,595,543
10.35%
Cost of revenue
1,179,700
1,467,643
1,379,301
Unusual Expense (Income)
NOPBT
288,098
317,936
216,242
NOPBT Margin
19.63%
17.81%
13.55%
Operating Taxes
44,414
56,546
43,728
Tax Rate
15.42%
17.79%
20.22%
NOPAT
243,684
261,390
172,514
Net income
266,968
6.34%
251,044
41.30%
177,666
2.28%
Dividends
(93,603)
(104,028)
(51,723)
Dividend yield
8.26%
5.61%
4.15%
Proceeds from repurchase of equity
31,213
(64,840)
BB yield
-2.76%
3.50%
Debt
Debt current
139,672
344,377
646,148
Long-term debt
654,086
1,254,687
763,791
Deferred revenue
1,254,687
763,791
Other long-term liabilities
(1,234,153)
(729,472)
Net debt
(297,476)
(188,293)
229,785
Cash flow
Cash from operating activities
484,363
648,237
409,758
CAPEX
(129,509)
(63,004)
(63,864)
Cash from investing activities
43,342
(44,086)
(52,754)
Cash from financing activities
(1,053,255)
(45,642)
(357,888)
FCF
517,332
413,382
223,888
Balance
Cash
411,937
1,036,418
478,653
Long term investments
679,297
750,939
701,501
Excess cash
1,017,844
1,698,078
1,100,377
Stockholders' equity
1,358,227
2,286,857
1,982,646
Invested Capital
2,127,895
3,129,103
3,246,702
ROIC
9.27%
8.20%
5.22%
ROCE
8.85%
6.31%
4.75%
EV
Common stock shares outstanding
1,920,196
1,911,693
1,915,677
Price
0.59
-39.18%
0.97
49.23%
0.65
-32.29%
Market cap
1,132,916
-38.90%
1,854,342
48.92%
1,245,190
-32.31%
EV
859,659
2,185,882
1,941,624
EBITDA
444,620
502,396
408,839
EV/EBITDA
1.93
4.35
4.75
Interest
78,708
67,445
25,687
Interest/NOPBT
27.32%
21.21%
11.88%